Search Orphan Drug Designations and Approvals
-
| Generic Name: | fatty acylated parathyroid (prodrug) hormone agonist |
|---|---|
| Date Designated: | 07/25/2022 |
| Orphan Designation: | Treatment of hypoparathyroidism |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
MBX Biosciences 275 Medical Drive, Unit 3904 Carmel, Indiana 46032 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







